HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nkere, U. U. Articles by Taylor, K. M. Search for Related Content PubMed PubMed Citation Articles by Nkere, U. U. Articles by Taylor, K. M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 106, 339-345, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass

UU Nkere, SA Whawell, EM Thompson, JN Thompson and KM Taylor
Royal Postgraduate Medical School, Hammersmith Hospital, London, England.

The presence of pericardial adhesions at resternotomy not only increases the operation time but also increases the risk of serious damage to the heart, great vessels, and extracardiac grafts. The reported prevalence of damage is 2% to 6%. The fibrinolytic activity of pericardial tissue may be a crucial factor in determining the extent of adhesion formation following primary operation. Ten patients undergoing cardiac operations were studied to assess the plasminogen activating activity of homogenates of pericardial tissue samples. Samples were taken at three times during the operation and the plasminogen activating activity was measured by means of a standard fibrin plate technique. Tissue-type plasminogen activator, urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and plasminogen activator inhibitor-2 were also measured by means of enzyme- linked immunosorbent assays. Compared with its initial levels (median 2.06 IU/cm2, range 1.28 to 6.48 IU/cm2), the plasminogen activating activity of pericardial biopsy tissue was significantly reduced at 75 minutes (median 0.64 IU/cm2, range 0.12 to 2.44 IU/cm2, p < 0.01) and at 135 minutes (median 1.45 IU/cm2, range 0.12 to 4.39 IU/cm2, p < 0.05). The major plasminogen activator present was tissue-type plasminogen activator. Compared with its initial levels (median 2.34 ng/ml, range 1.03 to 6.42 ng/ml), subsequent tissue-type plasminogen activator values were also significantly reduced at 75 minutes (median 0.83 ng/ml, range 0.75 to 5.13 ng/ml, p < 0.005) and at 135 minutes (median 1.24 ng/ml, range 0.75 to 6.67 ng/ml, p < 0.05). Low levels of urokinase-type plasminogen activator were found in 5 of 10 patients. However, neither plasminogen activator inhibitor-1 nor plasminogen activator inhibitor-2 was detected. Examination with a light microscope showed both increasing pericardial mesothelial damage and increasing features of acute inflammatory changes with time. This study shows that plasminogen activating activity is present in pericardial tissue and that tissue-type plasminogen activator is the major plasminogen activator. The observed inflammatory changes and concomitant damage to the pericardial mesothelium, and the significant reductions in pericardial tissue-type plasminogen activator and plasminogen activating activity seen during cardiac operations, may be important factors contributing to the early development of pericardial adhesions.

This article has been cited by other articles:

				Y. Naito, T. Shin'oka, N. Hibino, G. Matsumura, and H. Kurosawa A novel method to reduce pericardial adhesion: A combination technique with hyaluronic acid biocompatible membrane. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 850 - 856. [Abstract] [Full Text] [PDF]

				A. A. Mangi and D. F. Torchiana Pericardial Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1465 - 1478. [Full Text]

				A. A. Mangi and D. F. Torchiana Pericardial Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1359 - 1372. [Full Text]

				M. M. Arriero, J. C. de la Pinta, M. Escribano, A. Celdran, L. Munoz-Alameda, J. Garcia-Canete, A. M. Jimenez, S. Casado, J. Farre, and A. Lopez-Farre Aspirin Prevents Escherichia coli Lipopolysaccharide- and Staphylococcus aureus-Induced Downregulation of Endothelial Nitric Oxide Synthase Expression in Guinea Pig Pericardial Tissue Circ. Res., April 5, 2002; 90(6): 719 - 727. [Abstract] [Full Text] [PDF]

				A. Hurle, M. de la Vega, J. J. Feijoo, V. G. Ray, C. Abad, G. Ponce, and J. L. Perez-Arellano Effect of Physical Protection on the Mesothelial Integrity of the Pericardium Ann. Thorac. Surg., April 1, 1997; 63(4): 1091 - 1094. [Abstract] [Full Text]

				S. Cicek and D. A. Theodoro Topical Aprotinin in Cardiac Operations: A Note of Caution Ann. Thorac. Surg., March 1, 1996; 61(3): 1039 - 1040. [Full Text]

				M. M. Arriero, J. C. de la Pinta, M. Escribano, A. Celdran, L. Munoz-Alameda, J. Garcia-Canete, A. M. Jimenez, S. Casado, J. Farre, and A. Lopez-Farre Aspirin Prevents Escherichia coli Lipopolysaccharide- and Staphylococcus aureus-Induced Downregulation of Endothelial Nitric Oxide Synthase Expression in Guinea Pig Pericardial Tissue Circ. Res., April 5, 2002; 90(6): 719 - 727. [Abstract] [Full Text] [PDF]